Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 223 of 6351
-
Can an immune booster after lung cancer surgery keep the disease at bay?
Disease control Recruiting nowThis multicenter, randomized, open-label, phase II trial is designed to evaluate the efficacy and safety of adjuvant sintilimab in patients with completely resected non-small cell lung cancer who remain at high risk of recurrence after neoadjuvant immunochemotherapy. Approximate…
Phase 2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Can adding radiation at the right time boost immunotherapy for aggressive lung cancer?
Disease control Recruiting nowImmunotherapy combined with chemotherapy has emerged as the standard of care for patients with extensive-stage small cell lung cancer (ES-SCLC). The incorporation of thoracic radiotherapy can enhance treatment efficacy. Currently, the main types of research investigating immunoth…
Phase 2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a shot replace the knife for skin cancer?
Disease control Recruiting nowThis study will test a study drug called cemiplimab to see if it can help treat early-stage Cutaneous Squamous Cell Carcinoma (CSCC), a type of skin cancer. Cemiplimab works by helping the immune system to kill cancer cells. It binds to a protein called Programmed cell Death-1 (P…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a sound wave calm addiction? ultrasound targets the Brain's craving center
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of applying low-intensity focused ultrasound targeting the nucleus accumbens in individuals with opioid or amphetamine use disorders. The main questions it aims to answer is: \- Low-intensity focused ultra…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New combo attack on aggressive breast cancer shows promise in early trial
Disease control Recruiting nowBackground: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer with limited treatment options. Research suggests that using High-Intensity Focused Ultrasound (HIFU) to destroy the tumor and/or PD-1 inhibitor drugs to activate the immune system before sta…
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a diabetes drug boost weight-loss surgery outcomes?
Disease control Recruiting nowObese patients exhibit considerable heterogeneity and complex comorbidities, making long-term effective management challenging with single therapies. While bariatric surgery remains the most effective weight-loss intervention, postoperative weight regain and metabolic deteriorati…
Sponsor: China-Japan Friendship Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Can a Four-Drug cocktail tame inoperable liver cancer?
Disease control OngoingThe objective of this clinical trial study is to determine whether intravenous chemotherapy with the Ralox regimen in combination with Anlotinib and Penpulimab has certain efficacy and high safety for patients with unresectable hepatocellular carcinoma. Overall design: This clin…
Early phase 1 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Mind over motion: Brain-Controlled robot may boost stroke recovery
Disease control CompletedAfter a stroke, many people have trouble walking. One way to practice walking again is with a wearable robot, called an exoskeleton, that supports the legs and guides them through a walking pattern. In most systems, a therapist or a sensor decides when each step starts. This stu…
Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can a tiny device fix a hole in the heart without open surgery?
Disease control Recruiting nowThe international multicenter registry aims to gather real-world data on patient outcomes and assess the procedural success and performance of various device occluders used in the transcatheter treatment of pediatric and adult patients with perimembranous ventricular septal defec…
Sponsor: Fondation Hôpital Saint-Joseph • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Can a Two-Week progesterone course buy more time in the womb?
Disease control CompletedThis randomised clinical trial aims to investigate the effect of daily vaginal progesterone supplementation on pregnancy prolongation and cervical length changes following arrested preterm labor in singleton pregnancies. The study will recruit pregnant women between 28 and 33 wee…
Sponsor: Dr. Soetomo General Hospital • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can a Two-Pronged antibody head off a bone marrow cancer before it starts?
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of CM-336, which is a BCMA/CD3 BiTE, in the treatment of high risk smoldering multiple myeloma.
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New trial aims to stop deadly blood clots with quick catheter action
Disease control Recruiting nowProspective, multicenter, open label, randomized controlled clinical trial to compare the effects of an early catheter-directed treatment plus conventional care with conventional care in patients with high-risk pulmonary embolism
Sponsor: Leipzig Heart Science gGmbH • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for kids with tough leukemia: targeted drugs added to chemo
Disease control Recruiting nowThis is a clinical trial testing whether the addition of one of two chemotherapy agents, dasatinib or venetoclax, can improve outcomes for children and young adults with newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma or mixed phenotype acute leukemia. Primary O…
Phase 2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a Clot-Removing procedure beat standard care for brain vein blockage?
Disease control OngoingBackground: It has not been extensively studied in differing populations that endovascular treatment (EVT) for acute and subacute CVST with multimodal imaging selection improves the functional outcome better than standard medical care based on the guidelines. Published experience…
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Fish oil in pregnancy may cut childhood asthma risk, major trial launches
Prevention Recruiting nowThe overall aim of the study is to develop a nutritional preventive fish oil supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that both supplementations in higher doses than recommended could…
Phase 3 • Sponsor: Professor Klaus Bønnelykke • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
A new strategy aims to close the HIV prevention gap for black gay men
Prevention Recruiting nowThe major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel…
Sponsor: Columbia University • Aim: Prevention
Last updated Sep 02, 2026 00:00 UTC
-
Can a grid of radiation beams shrink tumors that resist standard treatment?
Disease control Recruiting nowTo explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.
Phase 1/2 • Sponsor: Xu Zhi-yuan • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for rare eye cancer: experimental combo aims to shrink tumors and extend life
Disease control Recruiting nowThe purpose of this study is to measure the clinical benefits of the combination of RP2 and nivolumab as compared with the combination of nivolumab and ipilimumab in patients with metastatic uveal melanoma who have not been treated with immune checkpoint inhibitor therapy.
Phase 2/3 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for lung cancer: YL201 takes on relapsed SCLC in major trial
Disease control OngoingThis study was designed to compare the efficacy and safety of YL201 with Topotecan Hydrochloride in subjects with relapsed small cell lung cancer (SCLC).
Phase 3 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to cure chronic hepatitis b in landmark trial
Disease control OngoingThe study is to evaluate the efficacy and safety of AHB-137 in CHB participants. The total duration of the study, including screening phase, treatment phase and follow-up phase.
Phase 2 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC